Weiling He

5.0k citations

94 papers · 3.7k indexed · 2 hit papers · h-index 31

Impact in

Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Oncology top 5%
- Cancer Immunotherapy and Biomarkers

Papers in ⓘ

Cancer Research 29
- Cancer-related molecular mechanisms research 11
- Cancer, Hypoxia, and Metabolism 7
Oncology 28

Co-authors: Run Lin (8 shared papers)Zunfu Ke (12 shared papers)Yulong He (10 shared papers)Guohui Wan (6 shared papers)Yi Niu (4 shared papers)Ziyou Lin (4 shared papers)Arabella Wan (5 shared papers)Heng Liang (4 shared papers)
Journals: Journal of Translational Medicine (3 papers)Cell Reports (2 papers)World Journal of Surgical Oncology (2 papers)Cancer Research (2 papers)BMC Cancer (2 papers)
Partner nations: China United States South Korea

In The Last Decade

Weiling He

90 papers receiving 3.7k citations

Hit Papers

align trajectories log scale

RNA m ⁶ A methylation regulates sorafenib resistance in liver cancer through FOXO 3‐mediated autophagy 2020 · 359 citations

Peers

Countries citing papers authored by Weiling He

Since Specialization

Citations

This map shows the geographic impact of Weiling He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiling He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiling He more than expected).

Fields of papers citing papers by Weiling He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiling He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiling He. The network helps show where Weiling He may publish in the future.

Co-authors

The 25 scholars most cited alongside Weiling He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Weiling He Line = papers co-authored together Weiling He links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Global liver disease burdens and research trends: Analysis from a Chinese perspective Journal of Hepatology ·Jia Xiao, Fei Wang, Nai-Kei Wong, Jinhan He, Zhang Rui, Ruijuan Sun, Yanying Xu, Yingxia Liu, Wei Li, Kazuo Koike, Weiling He, Hong You, Yinglei Miao, Xiaowei Liu, Mingming Meng, Bin Gao, Hua Wang, Cui Li Hit paper breakdown →	2019	410
2	RNA m ⁶ A methylation regulates sorafenib resistance in liver cancer through FOXO 3‐mediated autophagy The EMBO Journal ·Ziyou Lin, Yi Niu, Arabella Wan, Dongshi Chen, Heng Liang, Xijun Chen, Lei Sun, Siyue Zhan, Liutao Chen, Chao Cheng, Xiaolei Zhang, Xianzhang Bu, Weiling He, Guohui Wan Hit paper breakdown →	2020	359
3	CD155T/TIGIT Signaling Regulates CD8+ T-cell Metabolism and Promotes Tumor Progression in Human Gastric Cancer Cancer Research ·Weiling He, Hui Zhang, Fei Han, Xinlin Chen, Run Lin, Wei Wang, Haibo Qiu, Zhenhong Zhuang, Qi Liao, Weijing Zhang, Qinbo Cai, Yongmei Cui, Wenting Jiang, Han Wang, Zunfu Ke	2017	261
4	Strategies to improve tumor penetration of nanomedicines through nanoparticle design Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology ·Ya‐Ru Zhang, Run Lin, Hongjun Li, Weiling He, Jin‐Zhi Du, Jun Wang	2018	230
5	Fatty Acid Oxidation Controls CD8+ Tissue-Resident Memory T-cell Survival in Gastric Adenocarcinoma Cancer Immunology Research ·Run Lin, Hui Zhang, Yujie Yuan, Qiong He, Jianwen Zhou, Shuhua Li, Yu Sun, Daniel Y. Li, Haibo Qiu, Wei Wang, Zhehong Zhuang, Bin Chen, Yonghui Huang, Chuwei Liu, Yingzhao Wang, Shirong Cai, Zunfu Ke, Weiling He	2020	169
6	miR‐124 inhibits cell proliferation in gastric cancer through down‐regulation of SPHK1 The Journal of Pathology ·Jintang Xia, Zhiqiang Wu, Chunping Yu, Weiling He, Haiqing Zheng, Yulong He, Weihua Jian, Lianzhou Chen, Luanjing Zhang, Wen Li	2012	156
7	Loss‐of‐Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia Hepatology ·Yi Niu, Ziyou Lin, Arabella Wan, Lei Sun, Shijia Yan, Heng Liang, Siyue Zhan, Dongshi Chen, Xianzhang Bu, Peiqing Liu, Ceshi Chen, Weiling He, Xiongbin Lu, Guohui Wan	2021	91
8	N6 -Methyladenosine Regulates mRNA Stability and Translation Efficiency of KRT7 to Promote Breast Cancer Lung Metastasis Cancer Research ·Feng Chen, Zhuojia Chen, Tao Guan, Yan Zhou, Lichen Ge, Haisheng Zhang, Yingmin Wu, Guanmin Jiang, Weiling He, Jiexin Li, Hongsheng Wang	2021	90
9	RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer Gut ·Lei Sun, Arabella Wan, Zhuolong Zhou, Dongshi Chen, Heng Liang, Chuwei Liu, Shijia Yan, Yi Niu, Ziyou Lin, Siyue Zhan, Shanfeng Wang, Xianzhang Bu, Weiling He, Xiongbin Lu, Anlong Xu, Guohui Wan	2020	86
10	Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progression Journal of Experimental & Clinical Cancer Research ·Kaitao Yuan, Jinning Ye, Zhenguo Liu, Yufeng Ren, Weiling He, Jianbo Xu, Yulong He, Yujie Yuan	2020	83
11	MicroRNA-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of NF-κB signaling Journal of Translational Medicine ·Jin-tang Xia, Lianzhou Chen, Weihua Jian, Kebing Wang, Yongzhen Yang, Weiling He, Yulong He, De Chen, Wen Li	2014	82
12	Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance Gastroenterology report ·Qinghai Li, Yingzhao Wang, Jian Tu, Chu-Wei Liu, Yujie Yuan, Run Lin, Weiling He, Shirong Cai, Yulong He, Jinning Ye	2020	80
13	New insights into the correlations between circulating tumor cells and target organ metastasis Signal Transduction and Targeted Therapy ·Qinru Zhan, Bixia Liu, Xiaohua Situ, Yuting Luo, Tongze Fu, Yanxia Wang, Zhongpeng Xie, Lijuan Ren, Ying Zhu, Weiling He, Zunfu Ke	2023	72
14	Lymphatic endothelial cell‐secreted CXCL1 stimulates lymphangiogenesis and metastasis of gastric cancer International Journal of Cancer ·Jianbo Xu, Changhua Zhang, Yulong He, Hui Wu, Zhao Wang, Song Wu, Wen Li, Weiling He, Shirong Cai, Wen-hua Zhan	2011	64
15	Overexpression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) is associated with tumour aggressiveness and poor prognosis in human non-small cell lung cancer Oncotarget ·Zunfu Ke, Weiling He, Yuanhui Lai, Xuefeng Guo, Sharon Chen, Shuhua Li, Yuefeng Wang, Liantang Wang	2014	64
16	Astrocyte elevated gene-1(AEG-1) induces epithelial-mesenchymal transition in lung cancer through activating Wnt/β-catenin signaling BMC Cancer ·Weiling He, Shanyang He, Zuo Wang, Hongwei Shen, Wenfeng Fang, Yang Zhang, Wei Qian, Millicent Lin, Yuan Jing-lun, Jinyang Wang, Wenhua Huang, Liantang Wang, Zunfu Ke	2015	62
17	The Effect of Oxidative Phosphorylation on Cancer Drug Resistance Cancers ·Ziyi Zhao, Yong Mei, Ziyang Wang, Weiling He	2022	58
18	N6-methyladenosine-induced ERRγ triggers chemoresistance of cancer cells through upregulation of ABCB1 and metabolic reprogramming Theranostics ·Zhuojia Chen, Long Wu, Jiawang Zhou, Xinyao Lin, Yanxi Peng, Lichen Ge, Cheng-Ming Chiang, Hui Huang, Hongsheng Wang, Weiling He	2020	57
19	N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis Molecular Therapy ·Ziyou Lin, Arabella Wan, Lei Sun, Heng Liang, Yi Niu, Yuan Deng, Shijia Yan, Qiao‐Ping Wang, Xianzhang Bu, Xiaolei Zhang, Kunhua Hu, Guohui Wan, Weiling He	2022	56
20	CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9 BMC Cancer ·Weiling He, Hui Zhang, Yuefeng Wang, Yanbin Zhou, Yifeng Luo, Yongmei Cui, Neng Jiang, Wenting Jiang, Han Wang, Di Xu, Shuhua Li, Zhuo Wang, Yangshan Chen, Yu Sun, Yang Zhang, Hsian‐Rong Tseng, Xuenong Zou, Liantang Wang, Zunfu Ke	2018	54

About Weiling He

Weiling He is a scholar working on Cancer Research, Oncology, Biological Psychiatry, Gastroenterology and Pulmonary and Respiratory Medicine, having authored 94 papers that have together received 3.7k indexed citations. Recurring topics across this work include RNA modifications and cancer (18 papers), Cancer-related molecular mechanisms research (11 papers), Nanoplatforms for cancer theranostics (10 papers), Gastric Cancer Management and Outcomes (8 papers), Epigenetics and DNA Methylation (8 papers), Cancer-related gene regulation (8 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Metastasis and carcinoma case studies (7 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (877 citations), Molecular Biology (1.9k citations), Immunology (557 citations) and Hepatology (199 citations). Weiling He has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Run Lin, Zunfu Ke, Yulong He, Guohui Wan, Yi Niu, Ziyou Lin, Arabella Wan, Heng Liang, Lei Sun and Xianzhang Bu. Their work appears in journals such as Journal of Translational Medicine, Cell Reports, World Journal of Surgical Oncology, Cancer Research and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact